首页> 外文期刊>Heart and Lung: The Journal of Critical Care >Prognostic value of microalbuminuria on admission in patients with acute pulmonary embolism
【24h】

Prognostic value of microalbuminuria on admission in patients with acute pulmonary embolism

机译:预后价值的微蛋白尿在急性肺栓塞患者

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: There have been no studies examining the effect of microalbuminuria on outcomes of patients with acute pulmonary embolism (APE). This study aimed to assess the association between microalbuminuria and in-hospital mortality in patients with APE. Methods: This retrospective study included all adult patients hospitalized due to APE between June 2015 and May 2018. Blood and urine samples were collected before the diagnostic procedures on admission. Patients were divided into 3 groups according to urinary albumin to creatinine ratio (UACR) levels: normoalbuminu-ria ( 300 mg/g). The primary endpoint of the study was in-hospital mortality. Results: A total of 154 consecutive patients (mean age 69.8 +/- 13.4 years, 51.9% female) were included, and 21 (13.6%) of the patients died during their in-hospital course. The prevalence of normoalbuminuria, microalbuminuria, macroalbuminuria was 70.1%, 23.4%, and 6.5%, respectively. Patients with in-hospital mortality had significantly lower estimated glomerular filtration rate (eGFR), but higher UACR at admission than those patients who survived. As compared with patients with normoalbuminuria, multivariate analyses showed that the patients with microalbuminuria and macroalbuminuria had 2.38-, and 3.48-fold higher risk for in hospital mortality, respectively (p 0.001). Multivariate analyses also showed that UACR 102.6 mg/g (OR: 1.76; 95% CI, 0.99-3.16; p = 0.011) was independently associated with in-hospital mortality, while a low eGFR was not associated. Conclusion: Microalbuminuria at admission may allow rapid prediction of prognosis in patients with APE. (c) 2020 Elsevier Inc. All rights reserved.
机译:目标:没有研究微蛋白尿的影响的结果急性肺栓塞患者(猿)。本研究旨在评估协会微白蛋白尿与住院患者的死亡率猿。回顾性研究包括所有成年患者2015年6月之间由于猿可能住院2018. 在入院时诊断程序。根据患者分为3组尿白蛋白肌酐比率(UACR)关卡:normoalbuminu-ria (300 mg / g)。这项研究的主要终点是住院死亡率。患者(平均年龄69.8 + / - 13.4年,51.9%包括女性),21例(13.6%)患者在住院期间死亡。所料的患病率正常蛋白尿,微量白蛋白尿,macroalbuminuria是70.1%,分别为23.4%和6.5%。住院死亡率显著降低估计肾小球滤过率(eGFR),但是更高的UACR比病人在入院活了下来。normoalbuminuria、多元分析微蛋白尿患者macroalbuminuria 2.38,高3.48倍分别在医院死亡率的风险(p0.001)。UACR 102.6毫克/ g (OR: 1.76;0.011)是独立相关住院死亡率,而表皮生长因子受体并不低相关联的。入学可能允许快速预测预后患者的猿。版权。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号